Management of swallowing disorders in multiple sclerosis

Neurological Sciences

Volumn 27, Issue SUPPL. 4, 2006, Pages

  Restivo, D A ^a   Marchese Ragona, R ^b   Patti, F ^c  

^a GARIBALDI HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Botulinum toxin; Dysphagia; EMG (electromyography); Multiple sclerosis; Swallowing disorders

Indexed keywords

BOTULINUM TOXIN A; CALCIUM ANTAGONIST; NIFEDIPINE; PROTON PUMP INHIBITOR; SALIVA SUBSTITUTE;

ARTICLE; ASPIRATION PNEUMONIA; CAUSE OF DEATH; DEHYDRATION; DIET THERAPY; DYSPHAGIA; ENTERIC FEEDING; ESOPHAGUS MYOTOMY; EXERCISE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERSALIVATION; HYPOSALIVATION; MORBIDITY; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PREVALENCE; SYMPTOM; UPPER ESOPHAGUS SPHINCTER;

EID: 33750879241     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0655-2     Document Type: Article

References (20)

1. Jean A (2001) Brain stem control of swallowing: Neuronal network and cellular mechanisms. Physiol Rev 81:929-969
2. Prosiegel M, Schelling A, Wagner-Sonntag E (2004) Dysphagia in multiple sclerosis. Int MS J 11:22-31
3. Restivo DA, Maimone D, Patti F et al (2005) Trismus after stroke/TBI: botulinum toxin benefit and use pre-PEG placement. Neurology 64:2152-2153
4. Thomas FJ, Wiles CM (1999). Dysphagia and nutritional status in multiple sclerosis. J Neurol 246:677-682
5. Pappalardo A, Patti F, Restivo DA, Reggio A (2004) Symptomatic management in multiple sclerosis. Clin Ter 155:505-528, Review
6. Patti F, Emmi N, Restivo DA et al (2002) Neurogenic dysphagia: physiology, physiopathology and rehabilitative treatment. Clin Ter 153:403-419, Review
7. Park C, O'Neill PA (1994) Management of neurological dysphagia. Clin Rehabil 8:166-174
8. Mathews WB, Acheson ED, Batchelor JR, Weller RO (1985) McAlpines's multiple sclerosis. Churchill Livingstone, Edinburgh, London, Melbourne, New York, p 85
9. Abraham S, Scheinberg LC, Smith CR, LaRocca NG (1997) Neurologic impairment and disability status in outpatients with multiple sclerosis reporting dysphagia symptomatology. J Neurol Rehab 11:7-13
10. Calcagno P, Ruoppolo G, Grasso MG et al (2002) Dysphagia in multiple sclerosis - prevalence and prognostic factors. Acta Neurol Scand 105:40-43
11. De Pauw A, Dejaeger E, D'hooghe B, Carton H (2002) Dysphagia in multiple sclerosis. Clin Neurol Neurosurg 104:345-351
12. Abraham SS, Yun PT (2002) Laryngopharyngeal dysmotility in multiple sclerosis. Dysphagia 17:69-74
13. Bhatia KP, Munchau A, Brown P (1999) Botulinum toxin is a useful treatment in excessive drooling in saliva. J Neurol Neurosurg Psychiatry 67:697
14. Jost WH (1999) Treatment of drooling in Parkinson's disease with botulinum toxin. Mov Disord 14:1057
15. Perez I, Smithard DG, Davies H, Kalra L (1998) Pharmacological treatment of dysphagia in stroke. Dysphagia 13:12-16
16. McKenna JA, Dedo HH (1991) Cricopharyngeal myotomy: Indications and technique. Ann Otol Rhinol Laryngol 101:216-221
17. Restivo DA, Marchese-Ragona R, Staffieri A, De Grandis D (2000) Successful botulinum toxin treatment of dysphagia in oculopharyngeal muscular dystrophy. Gastroenterology 119:1416
18. Restivo DA, Giuffrida S, Marchese Ragona R, Falsaperla R (2001) Successful botulinum toxin treatment of dysphagia in a young child with nemaline myopathy. Dysphagia 16:228-229
19. Restivo DA, Palmeri A, Marchese-Ragona R (2002). Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N Engl J Med 346:1174-1175
20. Marchese-Ragona R, De Grandis D, Restivo DA et al (2003) Recovery of swallowing disorders in patients undergoing supracricoid laryngectomy with botulinum toxin therapy. Ann Otol Rhinol Laryngol 112:258-263